Skip to content
Lower risk Medical device recall · FDA · Published July 14, 2022

Philips EPIQ Ultrasound Systems with X5-1c Transducer May Reboot Unexpectedly

Philips recalls EPIQ ultrasound systems used with X5-1c transducers that may unexpectedly reboot, causing transducer damage. Affected units have specific model numbers and software versions.

🇺🇸 FDA recall #Z-1007-2026Medical devicePhilips ›
Take action

Contact the company

Recalling firmPhilips Ultrasound, LLC22100 Bothell Everett Hwy · Bothell, WA 98021-8431
✎ GovInfoNow plain-language explainer

Philips is recalling ultrasound systems that may unexpectedly reboot when used with the X5-1c transducer, potentially damaging the transducer. This could lead to costly repairs or replacements for healthcare facilities using these systems. Read more at govinfonow.com/recall/60364-philips-epiq-ultrasound-systems-with-x5-1c-transducer-may-reboot.

Source Summary by GovInfoNow · govinfonow.com/recall/60364-philips-epiq-ultrasound-systems-with-x5-1c-transducer-may-reboot · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1007-2026

Cite this page

“Philips EPIQ Ultrasound Systems with X5-1c Transducer May Reboot Unexpectedly.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/60364-philips-epiq-ultrasound-systems-with-x5-1c-transducer-may-reboot. Based on FDA recall #Z-1007-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1007-2026%22&limit=1).

Philips Ultrasound, LLC recalled Philips EPIQ Ultrasound Systems used with X5-1c transducers due to potential transducer damage from unexpected automatic reboots, according to the FDA on July 14, 2022.

How to tell if you have it

  • Philips EPIQ Ultrasound Systems (various models) with X5-1c transducer REF: 795200, 795201
  • REF: 795231, 795232, 795234
  • REF: 795117, 795122
  • Software Version Numbers: 9.0, 9.01, 9.02
  • UPC 00884838047693, UPC 00884838097933, UPC 00884838107441, UPC 00884838107533, UPC 00884838107540

The hazard

The ultrasound may experience an unexpected automatic reboot, resulting in damage to the transducer.

Context

GovInfoNow's records show Philips Ultrasound, LLC has two other recalls on record since October 31, 2025. On August 7, 2026, Philips recalled EPIQ Elite Ultrasound Systems for inaccurate blood flow measurements due to a software issue. On October 31, 2025, Philips recalled Lumify Diagnostic Ultrasound Systems because iOS 18 compatibility issues may cause imaging failures. Other recent recalls of similar products include Olympus ShockPulse-SE Lithotripsy System Probes (November 14, 2025) and Philips Azurion 5 M12 X-ray System (March 3, 2026).

How to tell if you have this one

Check for model numbers 795200, 795201, 795231, 795232, or 795234 on the transducer. The affected units also have specific software versions: 9.0, 9.01, or 9.02.

  • Brand
    Philips
  • Product
    Philips EPIQ Ultrasound Systems (various models) used in conjunction with the X5-1c transducer REF: , , 795200, 795201
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Transducer Model

    Identify the transducer model number on the device to see if it matches the recalled numbers.

  2. Contact Philips Support

    Reach out to Philips for guidance on whether your unit is affected and next steps.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 49 states.

Alaska: named in the noticeAKMaine: named in the noticeMEVermont: named in the noticeVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: named in the noticeWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “Worldwide - US Nationwide distribution in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 3.5 years after the firm started it.

1. Firm started the recall: Jul 14, 202212. FDA classified it Class II: Dec 31, 202523. Published in FDA’s Enforcement Report: Jan 7, 2026320222026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1007-2026 (July 14, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1007-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA